Von Willebrand factor/factor VIII concentrate (Humate-P®) for surgical prophylaxis of excessive bleeding in patients with von Willebrand disease (VWD).

被引：0
|
作者：
Gill, JC
DiPaola, J
Bernstein, J
Leissinger, CA
Valentino, L
Friedman, C
Knaub, S
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Blood Ctr Wisconsin, Milwaukee, WI 53226 USA
[3] Univ Iowa, Iowa City, IA USA
[4] Hemophilia Treatment Ctr, Las Vegas, NV USA
[5] Tulane Univ, Sch Med, New Orleans, LA 70118 USA
[6] Rush Presbyterian St Lukes Hemophilia Ctr, Chicago, IL USA
[7] ZLB Behring LLC, King Of Prussia, PA USA
[8] ZLB Behring GmbH, Marburg, Germany
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1791
引用
收藏
页码：509A / 509A
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of von Willebrand factor/factor VIII concentrate (Humate-P®) for prophylaxis of excessive bleeding during elective surgery in patients with von Willebrand disease.
    Bernstein, Jonathan
    Gill, Joan Cox
    Leissinger, Cindy A.
    Di Paola, Jorge
    Ragni, Margaret V.
    Shopnick, Rinah
    Valentino, Leonard A.
    Friedman, Carl
    Knaub, Sigurd
    [J]. BLOOD, 2006, 108 (11) : 98B - 98B
  • [2] von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease
    Gill, J. C.
    Shapiro, A.
    Valentino, L. A.
    Bernstein, J.
    Friedman, C.
    Nichols, W. L.
    Manco-Johnson, M.
    [J]. HAEMOPHILIA, 2011, 17 (06) : 895 - 905
  • [3] Pharmacokinetics and dose linearity of von Willebrand factor factor VIII concentrate (Humate-P®) in elective surgery in von Willebrand disease patients.
    DiPaola, J
    Gill, J
    Bernstein, J
    Leissinger, C
    Valentino, L
    Friedman, C
    Knaub, S
    [J]. BLOOD, 2005, 106 (11) : 509A - 510A
  • [4] Successful treatment of emergent surgery in patients with von Willebrand disease (vWD) treated with factor VIII/vWF concentrate (Humate-P®).
    Ewenstein, BM
    Gill, JC
    Thompson, A
    Xie, F
    Schwartz, BA
    [J]. BLOOD, 2000, 96 (11) : 48A - 48A
  • [5] Human Plasma von Willebrand Factor/Factor VIII Complex (Haemate® P/Humate-P®)In von Willebrand Disease and Haemophilia A
    Natalie J. Carter
    Lesley J. Scott
    [J]. Drugs, 2007, 67 : 1513 - 1519
  • [6] Human plasma von Willebrand factor/factor VIII complex (Haemate® P/Humate-P®) -: In von Willebrand disease and haemophilia A
    Carter, Natalie J.
    Scott, Lesley J.
    [J]. DRUGS, 2007, 67 (10) : 1513 - 1519
  • [7] Efficacy and safety of the Factor VIII/von Willebrand factor concentrate, Haemate-P/Humate-P: Ristocetin cofactor unit dosing in patients with von Willebrand disease
    Lillicrap, D
    Poon, MC
    Walker, I
    Xie, F
    Schwartz, BA
    [J]. THROMBOSIS AND HAEMOSTASIS, 2002, 87 (02) : 224 - 230
  • [8] von Willebrand factor/factor VIII concentrate (Humate-P®) is safe and effective in the prevention of perioperative bleeding in patients with very low von willebrand factor:: Ristocetin cofactor (VWF:RCo).
    Gill, Joan Cox
    Leissinger, Cindy A.
    DiPaola, Jorge
    Bernstein, Jonathan
    Ragni, Margaret V.
    Shopnick, Rinah
    Valentino, Leonard A.
    Knaub, Sigurd
    Friedman, Carl
    [J]. BLOOD, 2006, 108 (11) : 97B - 97B
  • [9] Human plasma von Willebrand factor/factor VIII complex (Haemate® P/Humate-P®) in von Willebrand disease and haemophilia A -: A viewpoint
    Berntorp, Eric
    [J]. DRUGS, 2007, 67 (10) : 1520 - 1520
  • [10] von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease
    Sidonio Jr, Robert F.
    Boban, Ana
    Dubey, Leonid
    Inati, Adlette
    Kiss, Csongor
    Boda, Zoltan
    Lissitchkov, Toshko
    Nemes, Laszlo
    Novik, Dzmitry
    Peteva, Elina
    Taher, Ali T.
    Timofeeva, Margarita Arkadevna
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Werner, Sylvia
    Knaub, Sigurd
    Khayat, Claudia Djambas
    [J]. BLOOD ADVANCES, 2024, 8 (06) : 1405 - 1414
12345